Loading market data...
Tuesday, August 4, 2026
Back to HomeStock AnalysisPremium

Northrop (NOC) Q2 2026: Record $104.7B Backlog, Margin 10.1%

By MinJeKim0 views
Share
Northrop (NOC) Q2 2026: Record $104.7B Backlog, Margin 10.1%

Northrop (NOC) Q2 2026: Record $104.7B Backlog, Margin 10.1%

Northrop Grumman's order book crossed $100 billion for the first time — backlog reached $104.7 billion at June 30, 2026, up 16.7% from $89.7 billion a year earlier and up about 9% from year-end 2025 — yet second-quarter operating income fell 23% to $1,096 million and the operating margin compressed to 10.1% from 13.8%. The composition of that record matters as much as the size: of roughly $20.0 billion in second-quarter net awards, $7.6 billion came from a single line — the 10-Q discloses that further definition and authorisation of the Sentinel program execution plan "result[ed] in a $7.6 billion increase in program backlog." That is a cost-type EMD restructure being formally scoped, not a newly competed win, and it carries the margin profile of cost-plus work. Strip it out and the quarter's book-to-bill on genuinely new business is far less spectacular than the headline implies.

Most of the headline earnings decline is an artifact of the prior-year $231 million gain on the training services divestiture, but the underlying picture is not flattering either: segment operating income slipped 5.0% to $1,158 million on sales that rose 5.1% to $10,876 million, and the earnings that did survive were carried by an effective tax rate of 6.3% rather than by program performance. For a prime contractor entering a defense budget cycle in which the FY2027 request — roughly $1.5 trillion, some 44% above the FY2026 level, though about $350 billion of that arrives through mandatory reconciliation funding rather than regular appropriations and none of it is enacted yet — points to years of expanding demand, the question is no longer whether demand exists. It is whether Northrop can convert record demand into margin.


1. Condensed Consolidated Statement of Financial Position

1-1. Principal asset movements

ItemDec 31, 2025 ($M)Jun 30, 2026 ($M)Change %
Cash and cash equivalents4,4032,307−47.6
Accounts receivable, net1,3752,311+68.1
Unbilled receivables (contract assets)6,5447,953+21.5
Inventoried costs, net1,3091,415+8.1
Property, plant and equipment, net10,97210,297−6.2
Goodwill17,43717,439+0.0
Total assets51,37750,763−1.2

Two lines deserve attention. First, receivables. Accounts receivable and unbilled receivables together rose to $10,264 million from $7,919 million at year-end — but half-year comparisons flatter the trend, because Northrop's billing cycle always builds working capital in the first half. The honest comparison is year-over-year: at June 30, 2025 the same two lines totalled $9,329 million, so the balance grew 10.0% against sales growth of 5.1%. Receivables are still outrunning revenue by roughly two to one, and unbilled receivables — revenue recognized under cost-to-cost before the customer has been billed — account for the bulk of it.

Unlimited U.S.-market analysis, $9.99/month

Northrop (NOC) Q2 2026: Record $104.7B Backlog, Margin 10.1%

This article became available on August 4, 2026. Subscribe to read in full, or wait until November 2, 2026 when it becomes free.

Cancel anytime. Full refund within 7 days.

NewsFinanceMarkets

Go deeper than the headline

You just read what happened. Here's how to read what it means.

Free daily briefing

The U.S. market, every morning — free

LineVest Daily lands in your inbox before every opening bell: the key U.S. markets stories, earnings, disclosures and foreign flows — in plain English. Free, no card required.

Get LineVest Daily — free →
This filing

Full report on this filing

We read this company's latest SEC filing in full — financials under US GAAP, governance, and what it means for the stock. PDF in your inbox within 3 hours.

$12 · one-time

Get the full report
Every name you watch

Follow the whole market

Reading several U.S. stocks a week? Read every analysis article the moment it publishes — full daily U.S. market coverage plus the 90-day archive.

$9.99 · monthly

Subscribe

Independent journalism based on primary SEC filings — not investment advice. No brokerage affiliation.